<?xml version="1.0" encoding="UTF-8"?>
<ref id="B45-pharmaceuticals-13-00455">
 <label>45.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lehmann</surname>
    <given-names>J.M.</given-names>
   </name>
   <name>
    <surname>McKee</surname>
    <given-names>D.D.</given-names>
   </name>
   <name>
    <surname>Watson</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Willson</surname>
    <given-names>T.M.</given-names>
   </name>
   <name>
    <surname>Moore</surname>
    <given-names>J.T.</given-names>
   </name>
   <name>
    <surname>Kliewer</surname>
    <given-names>S.A.</given-names>
   </name>
  </person-group>
  <article-title>The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions</article-title>
  <source>J. Clin. Investig.</source>
  <year>1998</year>
  <volume>102</volume>
  <fpage>1016</fpage>
  <lpage>1023</lpage>
  <pub-id pub-id-type="doi">10.1172/JCI3703</pub-id>
  <pub-id pub-id-type="pmid">9727070</pub-id>
 </element-citation>
</ref>
